Sex Hormones Flashcards
Therapeutic Estrogens
Estradiol, Ethinyl-estradiol, Estrone
Indications: primary hypogonadism, postmenopausal hormonal therapy, oral contraceptives, suppress ovulation in patients with intractable dysmenorrhea or hirsutism, fertility treatments
Side Effects: nausea, fluid retention, breakthrough bleeding, change in menstrual flow, breast tenderness
Adverse Effects: thromblytic complications; endometrial/breast carcinoma; HTN (IN MEN: feminization of genitalia & impotence)
Contraindications: pregnancy, incomplete bone growth, undiagnosed genital bleeding, stroke, thrombophlebitis, thromboembolic disease, heart disease; women with Hx of breast/uterine CA (BRCA gene)
DRUG INTERACTIONS: Decrease efficacy of anticoagulants and hypoglycemics; increase effects of tricyclic antidepressants; increase effects of oxytocin on uterus; St. John’s wort may lose efficacy of contraceptive or HRT of estrogens
Estradiol
Therapeutic estrogen
- main estrogen in premenopausal women
- poor oral bioavailability
- effective as a patch (ESTRADERM, ESTROGEL)
- IM lasts for weeks (DEPO Estradiol
- Topical with vaginal cream (Estring)
Ethinyl-esradiol
Therapeutic Estrogen
- commonly used for orl contraceptives
Estrone
Therapeutic Estrogen
- natural estrogen-main ingredient of conjugated estrogens (PREMARIN)
HRT Formations
DON’T HAVE TO KNOW ALL FOR TEST- JUST KNOW THAT MANY FORMS EXIST, including those in cream and patch forms, not just oral
Estrogen alone caused uterine (endometrial CA)- now combo with progestins (Medroxyprogesterone-MPA)
- various regimens now used- estrogen for 25 days with inclusion of MPA during last 10-13 days of estrogen, 5-6 days with no hormones
combo formulas
- PREMPRO (estrone plus MPA) given at fixed daily dose - PREMPHASE (Estrone for 28 days and MPA last 14-28 days)
Newer combos of estrogens with progestins:
- FEM HRT (estradiol plus norethindrone acetate)
- ORTH PREFEST(estradiol plus norgestimate)
- Vaginal creams (PREMARIN) or a ring device (ESTRING): can be used instead of oral doses . Reduces vaginal dryness, yeast infections and urinary tract infections.
CombiPatch (estradiol/norethindrone acetate) transdermal patch
Alcohol free, lasts 3.5 days
Tamoxifen
Selective Estrogen Receptor Modulator (SERM)
Good Effects: reduces breast CA risk, lowers LDL cholesterol, strengthens bones
Bad Effects: Increases uterine CA risk, increases blood clot risk (2-3 fold increase with DVT, PE)
- commonly used as an adjuvant with chemo or radiation in treatment
- preventative agent for women at high risk for breast CA
-* resistance usually develops in 5 years, may reflect alterations in the ER receptors in the tumors
Raloxifene (Evista)
- High affinity for both ER-a and ER-b (antagonist in breast, agonist in bone)
- Treatment of osteoporosis in post-menopausal women
- INVASIVE breast cancer in post-menopausal women (Less effect than tamoxifen against non-invasive)
More effective in women with a uterus than tamoxifen against invasive breast cancer, about the same as tamoxifen in women without a uterus - Does not cause proliferation of the endometrium or breast tumor cells
- No indication for pre-menopausal women, or men
Side effects: 2-3 fold ↑ risk of deep vein thrombosis and pulmonary embolism; Hot flashes (~25%)
Interactions: Ampicillin reduces absorption of raloxifene; Raloxifene reduces warfarin efficacy
Clomiphene
ANTI-ESTROGEN
- Weak agonist and strong antagonist for ER-a or ER-b (partial agonist)
- Oppose the negative feedback effects of endogenous estrogen. ↑amplitude of the LH and FSH pulses
- Major use: induction of ovulation in women with an intact hypothalamic-pituitary-ovarian axis (fertility treatment)
Adverse effects: multiple births, ovarian cysts
HRT Effects of Treatment (Estrogen effects associated tih HRT during menopause
GOOD:
strengthens bones, decreases LDL, increases HDL, reduces menopausal symptoms (hot flashes)
BAD:
increases risk for breast CA & uterine CA (uterine CA risk can be reduced or eliminated by using progesterone with estrogen), increases risk of blood clot (* increased risk of MI/stroke, especially in FIRST YEAR)
- therefore, contraindicated in women with personal/family Hx of CA or CV disease
ICI 182,870 / Fulvestrant (Faslodex)
ANTI-ESTROGEN
- pure estrogen antagonist
- effective in treating tamoxifen-resistant tumors
Progestins - Therapeutic progesterone
Naturally occurring progesterone (low oral bioavailability)
- Micronized particles suspended in oil and packaged in gelatin capsules (PROMETRIUM) - Vaginal gel (CRINONE) - Slow-release intrauterine device (PROGESTASERT)
Mechanism of Action: Interacts with PR to mimic the stimulatory affects of progesterone
Physiological Target: Reproductive Tract
- Decreases estrogen-driven endometrial proliferation
- Establishment and maintenance of pregnancy
Common Uses:
- Oral contraceptives
- HRT to limit estrogen’s effects on the endometrium
- Uterine Bleeding disorders
- Premature labor (decrease uterine contractions)
- Stimulate Appetite in AIDS or cancer patients
Mifepristone (RU 486) (mifeprex)
Anti-progesterone (PR antagonist)
- Used in first trimester to terminate pregnancy(along with prostaglandins to increase uterine contractions)
- Post-coital contraceptive (prevent implantation)
- Investigational: induction of labor after fetal death and treatment of endometriosis.
Adverse Effects: vaginal bleeding, abdominal pain and cramping
Contraindicated in patients with vaginal bleeding, adrenal dysfunction or asthma (due to anti-glucocorticoid actions)
Interactions:
- Decreases efficacy of anticoagulants.
- Inhibits hepatic metabolism by CYP3A4 (eg.anti-retroviral protease inhibitors, calcium-channel blockers, carbamazepine)
Mestranol / Ethinyl Estradiol
Contraception- therapeutic estrogens
- Absorbed efficiently in GI tract. Mestranol is biologically inactive and must be metabolized to ethinyl estradiol. Peak plasma levels within 1 hr after oral administration
- Clearance is ~ 60% 24 hr after oral dose
- Ethinyl estradiol is 2X more potent than mestranol
Norethindrone
Contraception- therapeutic estrogens
19-NOR Steroids : * Progestins
- Removal of 19-carbon changed major hormonal effect from an androgen to progestin while maintaining oral activity
- *Estranes: have some androgenic activity as well as estrogenic/anti-estrogenic actions. Rapidly absorbed (Norethindrone)
Norgestrel, Norgestimate, Desogestrel
Contraception- therapeutic estrogens
- Gonanes (progestins)
- More potent than estranes and less androgenic activity and are now used in the 3rd generation combination oral contraceptives